Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7
- PMID: 33704818
- PMCID: PMC8206967
- DOI: 10.1002/jmv.26931
Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7
Abstract
A newly emerged strain of SARS-CoV-2 of B.1.1.7 lineage has caused a significant surge in the SARS-CoV-2 infections in the UK. In this study, changes in the epitopes of spike and orf8 proteins in SARS-CoV-2 of B.1.1.7 lineage were investigated. Genomic alignment of the SARS-CoV-2/B.1.1.7 with SARS-CoV-2/Wuhan showed the presence of several mutations in orf1a/b, spike, orf8, and N proteins of SARS-CoV-2/B.1.1.7. Molecular models of spike and orf8 proteins were constructed by homology modeling. Superimposition between the spike proteins of SARS-CoV-2/Wuhan and SARS-CoV-2/B.1.1.7 showed noticeable variations in the spatial orientation in Val70-Asn74 and Thr250-Ser255 regions. This may have also resulted in the extension of the epitopic region at Ser244-Gly249 in the SARS-CoV-2/B.1.1.7 spike protein. Superimposition of the SARS-CoV-2/B.1.1.7 spike protein over Fab-spike protein complexes of SARS-CoV-2/Wuhan also showed subtle variations in the antibody binding affinity targeting the N-terminal domain of the spike protein. Epitopic variations were also observed between the corresponding orf8 regions of SARS-CoV-2/Wuhan and SARS-CoV-2/B.1.1.7. Moreover, the presence of a stop codon at position 27 in orf8 connotes the emergence of two frames (orf8a and orf8b) in SARS-CoV-2, which further hampers its extracellular secretion, and in turn, immunogenicity. The findings of the present study could further be used to develop targeted immunotherapeutics.
Keywords: B.1.1.7; COVID-19; Orf8; SARS-CoV-2; spike protein.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures
References
-
- WHO . Weekly operational update on COVID‐19 ‐ 13 February 2021. https://www.who.int/publications/m/item/weekly-operational-update-on-cov...
-
- Chand M, Hopkins S, Dabrera G, et al. Investigation of novel SARS‐COV‐2 variant: Variant of Concern 202012/01. Public Health England. 2020. https://www.gov.uk/government/publications/investigation-of-novel-sars-c...
-
- Rambaut A, Loman N, Pybus O, et al. Preliminary genomic characterisation of an emergent SARS‐CoV‐2 lineage in the UK defined by a novel set of spike mutations. Written on behalf of COVID‐19 Genomics Consortium UK. 2020. https://virological.org/t/preliminary-genomic-characterisation-of-an-eme...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
